AGÕæÈ˹ٷ½

STOCK TITAN

[Form 4] Apogee Therapeutics, Inc. Insider Trading Activity

Filing Impact
(High)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

Texas Roadhouse, Inc. (TXRH) filed a Form 4 on 07/03/2025 disclosing an equity award to Interim Chief Financial Officer Keith Humpich. On 07/02/2025, Humpich received 2,114 Restricted Stock Units (RSUs) under the company’s 2021 Long-Term Incentive Plan. Each RSU represents the conditional right to receive one share of common stock on 07/02/2026, contingent upon continued service. The filing shows no sales or purchases of common stock; it merely reports the grant and the officer’s post-grant ownership of 20,059 shares held directly.

The RSU award aligns executive compensation with shareholder value but is modest relative to Texas Roadhouse’s overall share count and market capitalization. The transaction is routine, indicates no change in strategic outlook, and does not materially affect the company’s capitalization or insider ownership structure.

Texas Roadhouse, Inc. (TXRH) ha presentato un Modulo 4 il 03/07/2025 comunicando un premio azionario all'Amministratore Delegato ad interim Keith Humpich. Il 02/07/2025, Humpich ha ricevuto 2.114 Unità di Azioni Vincolate (RSU) nell'ambito del Piano di Incentivi a Lungo Termine 2021 della società. Ogni RSU rappresenta il diritto condizionato a ricevere una azione ordinaria il 02/07/2026, subordinato al mantenimento dell'incarico. La comunicazione non indica vendite o acquisti di azioni ordinarie; segnala solo la concessione e la proprietà post-concessione dell'ufficiale di 20.059 azioni detenute direttamente.

Il premio in RSU allinea la retribuzione degli esecutivi al valore per gli azionisti, ma è modesto rispetto al numero complessivo di azioni e alla capitalizzazione di mercato di Texas Roadhouse. L'operazione è di routine, non indica cambiamenti nella strategia e non influisce in modo significativo sulla capitalizzazione o sulla struttura di proprietà interna della società.

Texas Roadhouse, Inc. (TXRH) presentó un Formulario 4 el 03/07/2025 revelando una concesión de acciones al Director Financiero Interino Keith Humpich. El 02/07/2025, Humpich recibió 2,114 Unidades de Acciones Restringidas (RSU) bajo el Plan de Incentivos a Largo Plazo 2021 de la compañía. Cada RSU representa el derecho condicional a recibir una acción común el 02/07/2026, condicionado a la continuidad en el servicio. La presentación no muestra ventas ni compras de acciones comunes; solo reporta la concesión y la propiedad posterior a la concesión del ejecutivo de 20,059 acciones en propiedad directa.

La concesión de RSU alinea la compensación ejecutiva con el valor para los accionistas, pero es modesta en relación con el total de acciones y la capitalización de mercado de Texas Roadhouse. La transacción es rutinaria, no indica cambios en la estrategia y no afecta materialmente la capitalización o la estructura de propiedad interna de la compañía.

Texas Roadhouse, Inc. (TXRH)ëŠ� 2025ë…� 7ì›� 3ì� 임시 최고재무책임ìž� Keith Humpichì—게 ì£¼ì‹ ë³´ìƒ ë‚´ì—­ì� 공개하는 Form 4ë¥� 제출했습니다. 2025ë…� 7ì›� 2ì�, HumpichëŠ� 회사ì� 2021ë…� 장기 ì¸ì„¼í‹°ë¸Œ 계íšì—� ë”°ë¼ 2,114ê°œì˜ ì œí•œ ì£¼ì‹ ë‹¨ìœ„(RSU)ë¥� 받았습니ë‹�. ê°� RSUëŠ� 2026ë…� 7ì›� 2ì¼ì— 1ì£� 보통주를 ë°›ì„ ì¡°ê±´ë¶€ 권리ë¥� 나타내며, ê³„ì† ê·¼ë¬´í•´ì•¼ 합니ë‹�. 제출 서류ì—는 보통ì£� 매매 ë‚´ì—­ì€ ì—†ìœ¼ë©�, 단지 ë³´ìƒ ë¶€ì—¬ì™€ ìž„ì›ì� ë³´ìƒ í›� ì§ì ‘ 보유 ì£¼ì‹ 20,059ì£�ë¥� 보고하고 있습니다.

RSU ë³´ìƒì€ ê²½ì˜ì§� 보수ë¥� 주주 가치와 연계하지ë§�, Texas Roadhouseì� ì „ì²´ ì£¼ì‹ ìˆ� ë°� 시가ì´ì•¡ì—� 비해 소규모입니다. ì� 거래ëŠ� ì¼ìƒì ì´ë©� ì „ëžµì � ì „ë§ ë³€í™”ê°€ ì—†ìŒì� 나타내고, 회사ì� ìžë³¸ 구조ë‚� ë‚´ë¶€ìž� 소유 구조ì—� 실질ì ì¸ ì˜í–¥ì� 미치지 않습니다.

Texas Roadhouse, Inc. (TXRH) a déposé un formulaire 4 le 03/07/2025 révélant une attribution d’actions à Keith Humpich, directeur financier par intérim. Le 02/07/2025, Humpich a reçu 2 114 unités d’actions restreintes (RSU) dans le cadre du plan d’incitation à long terme 2021 de la société. Chaque RSU représente le droit conditionnel de recevoir une action ordinaire le 02/07/2026, sous réserve de la poursuite du service. Le dépôt ne signale aucune vente ou achat d’actions ordinaires ; il rapporte uniquement l’attribution et la détention post-attribution de 20 059 actions détenues directement par le dirigeant.

L’attribution de RSU aligne la rémunération des dirigeants sur la valeur pour les actionnaires, mais reste modeste par rapport au nombre total d’actions et à la capitalisation boursière de Texas Roadhouse. La transaction est routinière, n’indique aucun changement de stratégie et n’affecte pas de manière significative la capitalisation ou la structure de propriété interne de l’entreprise.

Texas Roadhouse, Inc. (TXRH) reichte am 03.07.2025 ein Formular 4 ein, das eine Aktienzuteilung an den interimistischen Chief Financial Officer Keith Humpich offenlegt. Am 02.07.2025 erhielt Humpich 2.114 Restricted Stock Units (RSUs) im Rahmen des Long-Term Incentive Plans 2021 des Unternehmens. Jede RSU berechtigt unter der Bedingung fortgesetzter Dienstzeit zum Erhalt einer Stammaktie am 02.07.2026. Die Einreichung zeigt keine Verkäufe oder Käufe von Stammaktien; sie meldet lediglich die Zuteilung und den nach der Zuteilung gehaltenen Direktbestand von 20.059 Aktien des Offiziers.

Die RSU-Zuteilung richtet die Vergütung der Führungskräfte am Aktionärswert aus, ist jedoch im Verhältnis zur Gesamtzahl der Aktien und Marktkapitalisierung von Texas Roadhouse eher geringfügig. Die Transaktion ist routinemäßig, deutet auf keine Änderung der strategischen Ausrichtung hin und beeinflusst die Kapitalisierung oder die Insider-Besitzstruktur des Unternehmens nicht wesentlich.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Routine RSU grant to interim CFO; neutral impact on TXRH valuation and insider sentiment.

The Form 4 reports a standard compensation grantâ€�2,114 RSUs—worth roughly mid-six figures at recent prices. No shares were sold, so there is no negative selling signal. While the additional equity slightly increases insider alignment, the size is immaterial to share count and does not signal incremental confidence beyond normal compensation practices. Therefore, the filing is informational rather than market-moving.

Texas Roadhouse, Inc. (TXRH) ha presentato un Modulo 4 il 03/07/2025 comunicando un premio azionario all'Amministratore Delegato ad interim Keith Humpich. Il 02/07/2025, Humpich ha ricevuto 2.114 Unità di Azioni Vincolate (RSU) nell'ambito del Piano di Incentivi a Lungo Termine 2021 della società. Ogni RSU rappresenta il diritto condizionato a ricevere una azione ordinaria il 02/07/2026, subordinato al mantenimento dell'incarico. La comunicazione non indica vendite o acquisti di azioni ordinarie; segnala solo la concessione e la proprietà post-concessione dell'ufficiale di 20.059 azioni detenute direttamente.

Il premio in RSU allinea la retribuzione degli esecutivi al valore per gli azionisti, ma è modesto rispetto al numero complessivo di azioni e alla capitalizzazione di mercato di Texas Roadhouse. L'operazione è di routine, non indica cambiamenti nella strategia e non influisce in modo significativo sulla capitalizzazione o sulla struttura di proprietà interna della società.

Texas Roadhouse, Inc. (TXRH) presentó un Formulario 4 el 03/07/2025 revelando una concesión de acciones al Director Financiero Interino Keith Humpich. El 02/07/2025, Humpich recibió 2,114 Unidades de Acciones Restringidas (RSU) bajo el Plan de Incentivos a Largo Plazo 2021 de la compañía. Cada RSU representa el derecho condicional a recibir una acción común el 02/07/2026, condicionado a la continuidad en el servicio. La presentación no muestra ventas ni compras de acciones comunes; solo reporta la concesión y la propiedad posterior a la concesión del ejecutivo de 20,059 acciones en propiedad directa.

La concesión de RSU alinea la compensación ejecutiva con el valor para los accionistas, pero es modesta en relación con el total de acciones y la capitalización de mercado de Texas Roadhouse. La transacción es rutinaria, no indica cambios en la estrategia y no afecta materialmente la capitalización o la estructura de propiedad interna de la compañía.

Texas Roadhouse, Inc. (TXRH)ëŠ� 2025ë…� 7ì›� 3ì� 임시 최고재무책임ìž� Keith Humpichì—게 ì£¼ì‹ ë³´ìƒ ë‚´ì—­ì� 공개하는 Form 4ë¥� 제출했습니다. 2025ë…� 7ì›� 2ì�, HumpichëŠ� 회사ì� 2021ë…� 장기 ì¸ì„¼í‹°ë¸Œ 계íšì—� ë”°ë¼ 2,114ê°œì˜ ì œí•œ ì£¼ì‹ ë‹¨ìœ„(RSU)ë¥� 받았습니ë‹�. ê°� RSUëŠ� 2026ë…� 7ì›� 2ì¼ì— 1ì£� 보통주를 ë°›ì„ ì¡°ê±´ë¶€ 권리ë¥� 나타내며, ê³„ì† ê·¼ë¬´í•´ì•¼ 합니ë‹�. 제출 서류ì—는 보통ì£� 매매 ë‚´ì—­ì€ ì—†ìœ¼ë©�, 단지 ë³´ìƒ ë¶€ì—¬ì™€ ìž„ì›ì� ë³´ìƒ í›� ì§ì ‘ 보유 ì£¼ì‹ 20,059ì£�ë¥� 보고하고 있습니다.

RSU ë³´ìƒì€ ê²½ì˜ì§� 보수ë¥� 주주 가치와 연계하지ë§�, Texas Roadhouseì� ì „ì²´ ì£¼ì‹ ìˆ� ë°� 시가ì´ì•¡ì—� 비해 소규모입니다. ì� 거래ëŠ� ì¼ìƒì ì´ë©� ì „ëžµì � ì „ë§ ë³€í™”ê°€ ì—†ìŒì� 나타내고, 회사ì� ìžë³¸ 구조ë‚� ë‚´ë¶€ìž� 소유 구조ì—� 실질ì ì¸ ì˜í–¥ì� 미치지 않습니다.

Texas Roadhouse, Inc. (TXRH) a déposé un formulaire 4 le 03/07/2025 révélant une attribution d’actions à Keith Humpich, directeur financier par intérim. Le 02/07/2025, Humpich a reçu 2 114 unités d’actions restreintes (RSU) dans le cadre du plan d’incitation à long terme 2021 de la société. Chaque RSU représente le droit conditionnel de recevoir une action ordinaire le 02/07/2026, sous réserve de la poursuite du service. Le dépôt ne signale aucune vente ou achat d’actions ordinaires ; il rapporte uniquement l’attribution et la détention post-attribution de 20 059 actions détenues directement par le dirigeant.

L’attribution de RSU aligne la rémunération des dirigeants sur la valeur pour les actionnaires, mais reste modeste par rapport au nombre total d’actions et à la capitalisation boursière de Texas Roadhouse. La transaction est routinière, n’indique aucun changement de stratégie et n’affecte pas de manière significative la capitalisation ou la structure de propriété interne de l’entreprise.

Texas Roadhouse, Inc. (TXRH) reichte am 03.07.2025 ein Formular 4 ein, das eine Aktienzuteilung an den interimistischen Chief Financial Officer Keith Humpich offenlegt. Am 02.07.2025 erhielt Humpich 2.114 Restricted Stock Units (RSUs) im Rahmen des Long-Term Incentive Plans 2021 des Unternehmens. Jede RSU berechtigt unter der Bedingung fortgesetzter Dienstzeit zum Erhalt einer Stammaktie am 02.07.2026. Die Einreichung zeigt keine Verkäufe oder Käufe von Stammaktien; sie meldet lediglich die Zuteilung und den nach der Zuteilung gehaltenen Direktbestand von 20.059 Aktien des Offiziers.

Die RSU-Zuteilung richtet die Vergütung der Führungskräfte am Aktionärswert aus, ist jedoch im Verhältnis zur Gesamtzahl der Aktien und Marktkapitalisierung von Texas Roadhouse eher geringfügig. Die Transaktion ist routinemäßig, deutet auf keine Änderung der strategischen Ausrichtung hin und beeinflusst die Kapitalisierung oder die Insider-Besitzstruktur des Unternehmens nicht wesentlich.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Dambkowski Carl

(Last) (First) (Middle)
C/O APOGEE THERAPEUTICS, INC.
221 CRESCENT ST., BLDG. 17, STE. 102B

(Street)
WALTHAM MA 02453

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Apogee Therapeutics, Inc. [ APGE ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Medical Officer
3. Date of Earliest Transaction (Month/Day/Year)
07/02/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 07/02/2025 M 7,365 A $22.86 249,088 D
Common Stock 07/02/2025 S(1) 6,409 D $44.77(2) 242,679 D
Common Stock 07/02/2025 S(1) 2,935 D $45.49(3) 239,744 D
Common Stock 07/02/2025 S(1) 746 D $46.26(4) 238,998 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy) $22.86 07/02/2025 M 7,365 (5) 12/18/2033 Common Stock 7,365 $0.00 164,010 D
Explanation of Responses:
1. This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on August 21, 2024.
2. The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $44.12 to $45.11, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range.
3. The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.14 to $46.11, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
4. The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $46.16 to $46.43, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
5. This option represents the right to purchase 175,345 shares of the Issuer's common stock, which will vest in forty-eight equal monthly installments through December 18, 2027, subject to the Reporting Person's continued service to the Issuer.
/s/ Matthew Batters, as attorney-in-fact for Carl Dambkowski 07/03/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Texas Roadhouse (TXRH) file on July 3, 2025?

A Form 4 reporting insider equity activity for Interim CFO Keith Humpich.

How many Restricted Stock Units were granted to Interim CFO Keith Humpich?

He received 2,114 RSUs on July 2, 2025.

When do the granted RSUs to Keith Humpich vest?

The RSUs vest on July 2, 2026, with share delivery on that date.

How many Texas Roadhouse shares does Keith Humpich own after the transaction?

He directly owns 20,059 common shares following the reported grant.

Does the Form 4 show any insider selling of TXRH stock?

No. The filing reports an equity grant only; there were no sales or disposals.
Apogee Therapeutics Inc

NASDAQ:APGE

APGE Rankings

APGE Latest News

APGE Latest SEC Filings

APGE Stock Data

2.55B
41.42M
11.37%
130.16%
13.36%
Biotechnology
Biological Products, (no Disgnostic Substances)
United States
WALTHAM